|
⚲
|
| Keyboard |
| Veness Adam M
✚
|
|
|---|---|
| CIK # | 0001778623 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001778623] | |
| 4 | [0001778623] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Veness Adam M | |
| Dianthus Therapeutics Inc /DE/ | |
| Cyteir Therapeutics Inc | |
| Acceleron Pharma Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Dianthus Therapeutics Inc /DE/ DNTH
Stock Option (Right to Buy) · derivative
|
2026-02-03 | Grant | 100,000 | $0.00 | |
|
Dianthus Therapeutics Inc /DE/ DNTH
Stock Option (Right to Buy) · derivative
|
2025-02-03 | Grant | 100,000 | $0.00 | |
|
Dianthus Therapeutics Inc /DE/ DNTH
Stock Option (Right to Buy) · derivative
|
2024-05-23 | Grant | 75,000 | $0.00 | |
|
Dianthus Therapeutics Inc /DE/ DNTH
Stock Option (Right to Buy) · derivative
|
2024-01-24 | Grant | 110,000 | $0.00 | |
|
Cyteir Therapeutics Inc CYT
Stock Option (Right to Buy) · derivative
|
2023-02-03 | Grant | 96,100 | $0.00 | |
|
Cyteir Therapeutics Inc CYT
Stock Option (Right to buy) · derivative
|
2022-05-02 | Grant | 177,000 | $0.00 | |
|
Acceleron Pharma Inc XLRN
Option to Purchase Common Stock · derivative
|
2021-11-19 | Disposed to issuer | 6,700 | ||
|
Acceleron Pharma Inc XLRN
Common Stock
|
2021-11-19 | Tender | 23,423 | ||
|
Acceleron Pharma Inc XLRN
Option to Purchase Common Stock · derivative
|
2021-11-19 | Disposed to issuer | 18,806 | ||
|
Acceleron Pharma Inc XLRN
Option to Purchase Common Stock · derivative
|
2021-11-19 | Disposed to issuer | 24,334 | ||
|
Acceleron Pharma Inc XLRN
Option to Purchase Common Stock · derivative
|
2021-11-19 | Disposed to issuer | 8,500 | ||
|
Acceleron Pharma Inc XLRN
Option to Purchase Common Stock · derivative
|
2021-11-19 | Disposed to issuer | 7,650 | ||
|
Acceleron Pharma Inc XLRN
Option to Purchase Common Stock · derivative
|
2021-11-09 | Option exercise | 4,500 | $0.00 | |
|
Acceleron Pharma Inc XLRN
Common Stock
|
2021-11-09 | Option exercise | 4,500 | $29.37 | 132,165 |
|
Acceleron Pharma Inc XLRN
Option to Purchase Common Stock · derivative
|
2021-09-21 | Option exercise | 1,450 | $0.00 | |
|
Acceleron Pharma Inc XLRN
Common Stock
|
2021-09-21 | Option exercise | 5,200 | $30.17 | 156,884 |
|
Acceleron Pharma Inc XLRN
Common Stock
|
2021-09-21 | Option exercise | 1,450 | $41.20 | 59,740 |
|
Acceleron Pharma Inc XLRN
Common Stock
|
2021-09-21 | Sell | 6,650 | $150.05 | 997,833 |
|
Acceleron Pharma Inc XLRN
Option to Purchase Common Stock · derivative
|
2021-09-21 | Option exercise | 5,200 | $0.00 | |
|
Acceleron Pharma Inc XLRN
Common Stock
|
2021-09-09 | Sell | 1,407 | $130.00 | 182,910 |
| showing 20 of 48 most recent transactions | |||||